BENI DANG: Open Payments
NPI 1386101665 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 11 payments from 10 companies in 2025. Trend: 2023 $115 · 2024 $306 · 2025 $331
Food & beverage: $241Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $90 |
| 180 Medical, Inc. | 2 | $57 |
| Astellas Pharma US Inc | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| COLOPLAST CORP | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| UROGEN PHARMA, INC. | 1 | $21 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
Products named: ERLEADA, CURE CATHETER, Xtandi, LYNPARZA, Luja Coude, KEYTRUDA, ADSTILADRIN, PANHEMATIN.
Industry payments across OR — which companies pay providers there.
